← Leaderboards
Elizabeth Raynor
Beth Israel Deaconess Medical Center
$14,576
Attributed
$14,576
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$14,576 · 2
By mechanism
M01$14,576 · 2
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Seward B Rutkove$22,235,643
- David K. Simon$9,625,206
- Susan L Greenspan$27,746,173
- Steven C. Schachter$10,007,385
- K Lea Sewell$387,832
Others in their field
Top investigators on “Amyotrophic Lateral Sclerosis”
- Merit E Cudkowicz · Massachusetts General Hospital$54,029,758
- James Dale Berry · Brigham And Women'S Hospital$37,291,450
- Sabrina Paganoni · Massachusetts General Hospital$36,168,406
- Suma Babu · Massachusetts General Hospital$36,168,406
- Jeffrey D Rothstein · Massachusetts General Hospital$22,909,620
- Teepu Siddique · University Of Chicago$22,641,778
Research focus
Amyotrophic Lateral SclerosisClinical ResearchHuman SubjectHuman Therapy EvaluationClinical Trial Phase INervous System Disorder ChemotherapyNeuroprotectantsAnticonvulsantsClinical TrialsOxidoreductase InhibitorNonsteroidal Antiinflammatory AgentDrug Screening /EvaluationPathologic ProcessPatient Oriented Research
Grant awards (7)
CLINICAL TRIAL OF CELEBREX IN SUBJECTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS)$3,185
M01 · FY2005 · RR
Clinical Trial of Celebrex in Subjects with Amyotrophic Lateral Sclerosis (ALS)$11,391
M01 · FY2004 · RR
TOPIRAMATE IN AMYOTROPHIC LATERAL SCLEROSIS$0
M01 · FY2002 · RR
TOPIRAMATE IN AMYOTROPHIC LATERAL SCLEROSIS$0
M01 · FY2001 · RR
TOPIRAMATE IN AMYOTROPHIC LATERAL SCLEROSIS$0
M01 · FY2000 · RR
TOPIRAMATE IN AMYOTROPHIC LATERAL SCLEROSIS$0
M01 · FY2000 · RR
TOPIRAMATE IN AMYOTROPHIC LATERAL SCLEROSIS$0
M01 · FY2000 · RR